Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

Condition:   Locally Advanced Rectal Cancer Interventions:   Drug: capecitabine;   Drug: tislelizumab;   Drug: thymalfasin;   Radiation: long-term radiotherapy Sponsors:   Beijing Friendship Hospital;   Peking Union Medical College Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials